Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

13:00 ET German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Genomic Health announced today that the German Federal Joint Committee (G-BA) issued a positive reimbursement decision for the Oncotype DX Breast...


11:41 ET OxThera initiiert Verlängerungsteil einer Phase-3-Studie mit Oxabact bei primärer Hyperoxalurie

OxThera AB, ein biopharmazeutisches Unternehmen, das sich auf die Verbesserung des Lebens von Menschen mit primärer Hyperoxalurie konzentriert, gab...


11:39 ET OxThera initie la prolongation d'une étude de phase 3 sur Oxabact pour le traitement de l'hyperoxalurie primaire

OxThera AB, une société biopharmaceutique dédiée à l'amélioration de la vie des patients atteints d'hyperoxalurie primaire, a annoncé aujourd'hui que ...


10:29 ET Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 (5P12-RANTES) in colorectal cancer. BALB/c...


09:19 ET New Data Shows That Karius Blood Test Can Non-Invasively Detect Pathogens In Deep Infections

Karius, a life sciences company that delivers genomic insights for infectious diseases, announced new findings that show the potential clinical...


09:00 ET Florence Secures Patent Pioneering New Methods of Remote Monitoring in Clinical Trials

Today Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office for: "Remote Monitoring and...


09:00 ET Syqe Medical Receives Regulatory Approval to Release World's First Drug Delivery Device for Precise Dosing of Cannabis

Syqe Medical, a leading pharma-tech company, today announced the launch of the world's first pharmaceutical-grade metered-dose cannabis inhaler in...


08:20 ET Syntrix Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Clinical Trial of SX-682 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Melanoma

Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA®...


08:00 ET Medicenna Presents New Preclinical Results For its IL-2 Superkine Platform, MDNA109

-Long Acting MDNA109 provides durable tumor control and strong memory response without further treatment when combined with checkpoint inhibitors...


08:00 ET Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine

Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider for immuno-oncology...


07:50 ET 100+ Patients Treated for Erectile Dysfunction Utilizing Company's Patented CaverStem® Stem Cell Procedure with Significant Success Rate and No Adverse Effects Reported

Creative Medical Technology Holdings, Inc. (OTCQB: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and...


07:34 ET OxThera comienza la parte de ampliación de su estudio en Fase 3 de Oxabact en hiperoxaluria primaria

OxThera AB, una compañía biofarmacéutica dedicada a mejorar las vidas de las personas que padecen hiperoxaluria primaria, anunció hoy que ya han...


07:30 ET Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has...


07:14 ET Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly

Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders,...


07:00 ET Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based...


07:00 ET CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin, 20%, subcutaneous], at the 2019 Peripheral Nerve Society Annual Meeting

Global biotherapeutics leader CSL Behring today announced that it will support the presentation of eight scientific posters at the 2019 annual...


06:49 ET Cyxone Initiates First-in-human Trial With T20K for the Treatment of MS

Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company starts its first-in-human, phase I, clinical trial with...


04:00 ET OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria

OxThera AB, a biopharmaceutical company dedicated to improve the lives of people living with Primary Hyperoxaluria, today announced that the first...


Jun 19, 2019, 15:35 ET Quadrant Biosciences Takes Next Step in the Detection of Autism

Quadrant Biosciences Inc., a developer of epigenetic diagnostic technologies, has been awarded a $330,000 grant from the National Institutes of...


Jun 19, 2019, 14:05 ET Tout premier bras robotique contrôlé par l'esprit sans implants cérébraux

Une équipe de chercheurs de l'Université Carnegie Mellon, en collaboration avec l'Université du Minnesota, a fait une découverte capitale dans le...


Jun 19, 2019, 14:05 ET First-ever successful mind-controlled robotic arm without brain implants

A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of...


Jun 19, 2019, 14:05 ET Primer brazo robótico controlado por la mente que funciona sin implantes cerebrales

Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con la Universidad de Minnesota, hizo un hallazgo revolucionario en el ...


Jun 19, 2019, 14:05 ET Primeiro bem-sucedido braço robótico controlado pela mente sem implantes no cérebro

Uma equipe de pesquisadores da Universidade Carnegie Mellon, em colaboração com a Universidade de Minnesota, fez um grande progresso no campo do...


Jun 19, 2019, 14:05 ET Erster erfolgreich durch Gedanken gesteuerter Roboterarm - ohne Gehirnimplantate

Einem Forscherteam der Carnegie Mellon-Universität gelang in Zusammenarbeit mit der Universität von Minnesota ein Durchbruch im Bereich der...


Jun 19, 2019, 14:05 ET El primer brazo robótico exitoso de la historia controlado por la mente sin implantes cerebrales

Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con la Universidad de Minnesota, ha dado un gran paso de avance en el...